We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NATI
2101
DELISTED
National Instruments Corp
NATI
$21K ﹤0.01%
673
-4,507
-87% -$131K
PLXP
2102
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$21K ﹤0.01%
1,685
+1,643
+3,912% +$60.4K
CLGX
2103
DELISTED
Corelogic, Inc.
CLGX
$21K ﹤0.01%
564
-7,882
-93% -$305K
MIK
2104
DELISTED
Michaels Stores, Inc
MIK
$21K ﹤0.01%
+1,043
New +$24.2K
HMSY
2105
DELISTED
HMS Holdings Corp.
HMSY
$21K ﹤0.01%
+1,139
New +$22.2K
NEOS
2106
DELISTED
Neos Therapeutics, Inc
NEOS
$21K ﹤0.01%
+3,622
New +$24.5K
HDS
2107
DELISTED
HD Supply Holdings, Inc.
HDS
$21K ﹤0.01%
497
-739
-60% -$27.2K
MSBF
2108
DELISTED
MSB Financial Corp.
MSBF
$21K ﹤0.01%
1,424
-2,163
-60% -$30K
AKRX
2109
DELISTED
Akorn Inc
AKRX
$21K ﹤0.01%
975
-1,402
-59% -$32.3K
UBNK
2110
DELISTED
United Financial Bancorp, Inc.
UBNK
$21K ﹤0.01%
+1,120
New +$17.9K
TIS
2111
DELISTED
Orchids Paper Products, Inc.
TIS
$21K ﹤0.01%
776
+467
+151% +$12.1K
ANCX
2112
DELISTED
Access National Corp
ANCX
$21K ﹤0.01%
+759
New +$19.9K
HDP
2113
DELISTED
Hortonworks, Inc.
HDP
$21K ﹤0.01%
2,591
+1,599
+161% +$13.3K
FMI
2114
DELISTED
Foundation Medicine, Inc.
FMI
$21K ﹤0.01%
+1,195
New +$25.7K
RPXC
2115
DELISTED
RPX Corporation
RPXC
$21K ﹤0.01%
1,946
-1,474
-43% -$15.5K
XBKS
2116
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
$21K ﹤0.01%
+761
New +$18.9K
CCP
2117
DELISTED
Care Capital Properties, Inc.
CCP
$21K ﹤0.01%
846
-1,006
-54% -$25.2K
KCG
2118
DELISTED
KCG Holdings, Inc.
KCG
$21K ﹤0.01%
1,616
+1,302
+415% +$18.3K
ADPT
2119
DELISTED
Adeptus Health Inc
ADPT
$21K ﹤0.01%
+2,760
New +$50.8K
AAOI icon
2120
Applied Optoelectronics
AAOI
$10.9B
$20K ﹤0.01%
833
+333
+67% +$7.72K
AGX icon
2121
Argan
AGX
$8.37B
$20K ﹤0.01%
283
-347
-55% -$21.6K
ALDX icon
2122
Aldeyra Therapeutics
ALDX
$93.5M
$20K ﹤0.01%
3,760
+3,181
+549% +$18.7K
ALEX
2123
DELISTED
Alexander & Baldwin
ALEX
$20K ﹤0.01%
440
-253
-37% -$10.5K
ATEN icon
2124
A10 Networks
ATEN
$1.93B
$20K ﹤0.01%
+2,452
New +$21.1K
ATKR icon
2125
Atkore
ATKR
$3.16B
$20K ﹤0.01%
833
-38,400
-98% -$790K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.